Delivery Order SPE2DB22D2211-SPE2DB25FSGEX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Calquence 100 mg tablets (60-count units) valued at $22,375.12 under a firm fixed-price contract. This non-competitive delivery order, with an ultimate completion date of September 25, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical systems. The contract was performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed price arrangement. The contract ceiling value is $11,187.56, with an ultimate completion date of September 24, 2025. This is an unset-aside, competitively awarded delivery order executed as a child contract under AmerisourceBergen's larger pharmaceutical supply framework. The performance location is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $11,187.56. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for Calquence 100 mg tablets (60-count supply) valued at $5,593.77. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle, is scheduled for completion by October 17, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract was...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,593.77 on August 1, 2025, for the supply of Calquence 100 mg tablets (60 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 22, 2025, and performance to be fulfilled at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's broader relationship with DLA, leveraging the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Calquence 100 mg tablets (60-count units) valued at $5,593.77. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 30, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,187.56 for Calquence 100 mg tablets (60-count units) on August 11, 2025, with completion targeted for September 2, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract. The delivery order, valued at $5,593.77 with an ultimate completion date of October 21, 2025, represents a non-competitive, non-set-aside award supporting federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Calquence 100 mg tablets (60-count package) valued at $11,187.56. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement under the company's existing indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $5,593.77. This firm fixed-price delivery order is set to be completed by June 23, 2025, and represents performance from AmerisourceBergen's Conshohocken, Pennsylvania location. The award is issued under a competitive, non-set-aside procurement mechanism, reflecting AmerisourceBergen's established capability as a...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSGEXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract valued at $33,562.68, with completion scheduled for October 21, 2025. This non-set-aside award represents a competitive procurement action, consistent with AmerisourceBergen's established role as a critical pharmaceutical supplier to federal medical systems. The contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under a larger vehicle. This delivery order falls under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables comprehensive pharmaceutical support across multiple therapeutic domains for military healthcare programs globally, including deliveries to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's successful performance across numerous competitively awarded delivery orders demonstrates its capability to fulfill diverse federal medical procurement requirements, ranging from specialty medications to vaccines and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.6k | 9/29/25 |